BioCentury
ARTICLE | Financial News

Bonti completes venture financing

April 20, 2017 9:49 PM UTC

Botulinum neurotoxin play Bonti Inc. (Newport Beach, Calif.) raised $11.7 million in a series B round on April 18. RBV Capital, City Hill Ventures, Colt Ventures, JMCR Partners and HighLight Capital p...